The Role of Mesothelin in Tumor Progression and Targeted Therapy

间皮素 癌症研究 肿瘤科 癌症 医学 内科学
作者
Zhewei Tang,Min Qian,Mitchell Ho
出处
期刊:Anti-cancer Agents in Medicinal Chemistry [Bentham Science Publishers]
卷期号:13 (2): 276-280 被引量:119
标识
DOI:10.2174/1871520611313020014
摘要

Mesothelin, a glycosylphosphatidylinositol (GPI) anchored cell surface protein, is a potential target for antibody-based cancer therapy due to its high expression in mesothelioma, ovarian cancer, pancreatic cancer, cholangiocarcinoma and other cancers. The SS1P immunotoxin and MORAb-009 (amatuximab), a chimeric monoclonal antibody, are currently being evaluated in clinical trials. In this review, we discuss the role of mesothelin in cancer progression and provide new insights into mesothelin-targeted cancer therapy. Recent studies highlight three mechanisms by which mesothelin plays a role in cancer progression. First, mesothelin may aid in the peritoneal implantation and metastasis of tumors through its interaction with mucin MUC16 (also known as CA125). Second, mesothelin may promote cancer cell survival and proliferation via the NF-κB signaling pathway. Finally, mesothelin expression promotes resistance to certain chemotherapy drugs such as TNF-α, paclitaxel, and a combination of platinum and cyclophosphamide. However, its cancerspecific expression makes mesothelin a potential target for monoclonal antibody therapy. New human monoclonal antibodies targeting mesothelin have been isolated by phage display technology and may provide opportunities for novel cancer therapy. Keywords: Antibody dependent cell mediated cytotoxicity/ADCC, Apoptosis, Cell surface proteins, Cell survival/proliferation, Complement dependent cytotoxicity/CDC, Human monoclonal antibodies, Immunotoxin, Mesothelin, MORAb-009/amatuximab, MUC16/CA125, NF-κB, PI3K/Akt, SS1P
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
马亚飞发布了新的文献求助10
1秒前
haimianbaobao完成签到 ,获得积分10
2秒前
细心慕凝发布了新的文献求助10
4秒前
5秒前
饱满南松发布了新的文献求助10
8秒前
8秒前
赘婿应助科研通管家采纳,获得10
9秒前
MITNO1完成签到,获得积分10
9秒前
Bryan应助科研通管家采纳,获得10
9秒前
Bryan应助科研通管家采纳,获得10
10秒前
李健应助科研通管家采纳,获得10
10秒前
MchemG应助科研通管家采纳,获得10
10秒前
yx_cheng应助科研通管家采纳,获得30
10秒前
10秒前
隐形曼青应助科研通管家采纳,获得10
10秒前
科研通AI2S应助科研通管家采纳,获得10
10秒前
10秒前
10秒前
10秒前
10秒前
10秒前
祖丽完成签到,获得积分10
12秒前
13秒前
慕青应助饱满南松采纳,获得10
14秒前
Sylovia发布了新的文献求助30
14秒前
火星上惋庭完成签到 ,获得积分10
15秒前
YL发布了新的文献求助10
16秒前
18秒前
19秒前
无聊的火龙果应助江屿采纳,获得20
19秒前
英俊的铭应助虚幻初之采纳,获得10
20秒前
温柔的沉鱼完成签到,获得积分10
22秒前
澡雪发布了新的文献求助10
22秒前
23秒前
123完成签到,获得积分10
24秒前
L912294993完成签到,获得积分10
24秒前
搜集达人应助vg采纳,获得10
25秒前
迷路的寒云完成签到,获得积分10
27秒前
我是老大应助liars采纳,获得10
27秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975516
求助须知:如何正确求助?哪些是违规求助? 3519930
关于积分的说明 11200130
捐赠科研通 3256278
什么是DOI,文献DOI怎么找? 1798183
邀请新用户注册赠送积分活动 877425
科研通“疑难数据库(出版商)”最低求助积分说明 806320